Steven P. Coen sold $6,540 of DNA
See remarks at Ginkgo Bioworks Holdings, Inc.. 736 shares at an average of $8.89, traded Dec 15, 2025, filed Dec 16, 2025.
Score components
- +15RoleOfficer
- 0Trade size$7k at market
- 0Share of holdings soldSold 8.9% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +16.0%, 3m -17.3%, 6m -0.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-057441, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | MOption exercise Class A Common Stock | +1,174 | - | - | 7,912 | Dec 16, 2025 |
| Dec 12, 2025 | MOption exercise Class A Common Stock | +312 | - | - | 8,224 | Dec 16, 2025 |
| Dec 15, 2025 | SOpen-market sale Class A Common Stock | -736 | $8.89 | $6,540 | 7,488 | Dec 16, 2025 |
| Dec 12, 2025 | MOption exercise Restricted Stock Unitsderivative | -1,174 | - | - | 9,992 | Dec 16, 2025 |
| Dec 12, 2025 | MOption exercise Restricted Stock Unitsderivative | -312 | - | - | 4,223 | Dec 16, 2025 |
Related signals
Other insiders at Ginkgo Bioworks Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 1Weak | Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $36k 2,403 shares | -5% | |
| 26Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Christian O Henry director | $35k 5,000 shares | -21% | |
| 0Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $2,302 330 shares | -1% | |
| 0Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $5,943 752 shares | -1% | |
| 0Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $2,559 307 shares | -1% | |
| 15Weak | Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $2,576 324 shares | -1% | |
| 37Weak | Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $213k 33,171 shares | -40% | |
| 39Weak | Ginkgo Bioworks Holdings, Inc. | Barry Canton owner | $802k 124,727 shares | -22% | |
| 42Moderate | Ginkgo Bioworks Holdings, Inc. | Reshma P. Shetty See remarks | $802k 124,727 shares | -22% | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | Barry Canton owner | $175k 26,271 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.